mTORC1, the maestro of cell metabolism and growth
What this study shows
Comprehensive current review of how nutrients and growth signals are integrated by mTORC1 and the metabolic programs it commands, plus the clinical outlook for mTORC1-targeted therapy across cancer, neurodegeneration, obesity, diabetes and aging -- anchor reference for the pathway map.
At a glance
| Evidence type | R Review — secondary literature, not a new result Marked R because it is a review or synthesis of existing evidence rather than a new primary result; that is a different form of writing, not a weaker one. |
| Study type | Narrative Review |
| Model system | N/A (narrative review) |
| Journal | Genes & Development |
| Year | 2025 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1101/gad.352084.124 · PMID 39572234 · Free full text (PMC11789495) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | N/A (review) |
| Target | mTORC1 pathway (nutrient/growth factor integration) |
| Model | N/A |
| Effect | Comprehensive review of mTORC1 regulation, metabolic control, and clinical outlook |
In the Atlas
Related topics
Was this page useful?
Thank you. Your answer was counted anonymously.